The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Solid-phase Oligonucleotide Synthesis Market Research Report 2025

Global Solid-phase Oligonucleotide Synthesis Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1687316

No of Pages : 86

Synopsis
The global Solid-phase Oligonucleotide Synthesis market was valued at US$ 421 million in 2023 and is anticipated to reach US$ 1221.2 million by 2030, witnessing a CAGR of 16.8% during the forecast period 2024-2030.

North American market for Solid-phase Oligonucleotide Synthesis is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Solid-phase Oligonucleotide Synthesis is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Solid-phase Oligonucleotide Synthesis in Commercial is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Solid-phase Oligonucleotide Synthesis include Genescript, GeneArt (Thermofischer), Renesas Electronics Corporation, DNA 2.0 (ATUM), OriGene, BBI, Genewiz, Eurofins Genomics and Gene Oracle, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Solid-phase Oligonucleotide Synthesis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Solid-phase Oligonucleotide Synthesis.

Report Scope

The Solid-phase Oligonucleotide Synthesis market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Solid-phase Oligonucleotide Synthesis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Solid-phase Oligonucleotide Synthesis companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

Genescript

GeneArt (Thermofischer)

Renesas Electronics Corporation

DNA 2.0 (ATUM)

OriGene

BBI

Genewiz

Eurofins Genomics

Gene Oracle

SBS Genetech

Bio Basic

Segment by Type

Primers

Probes

Intermediate-scale Synthesis Oligos

Large-scale Synthesis Oligos

Linkers and Adaptors

Segment by Application

Commercial

Academic Research

By Region

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Solid-phase Oligonucleotide Synthesis companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Solid-phase Oligonucleotide Synthesis Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Primers

1.2.3 Probes

1.2.4 Intermediate-scale Synthesis Oligos

1.2.5 Large-scale Synthesis Oligos

1.2.6 Linkers and Adaptors

1.3 Market by Application

1.3.1 Global Solid-phase Oligonucleotide Synthesis Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Commercial

1.3.3 Academic Research

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Solid-phase Oligonucleotide Synthesis Market Perspective (2019-2030)

2.2 Solid-phase Oligonucleotide Synthesis Growth Trends by Region

2.2.1 Global Solid-phase Oligonucleotide Synthesis Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Solid-phase Oligonucleotide Synthesis Historic Market Size by Region (2019-2024)

2.2.3 Solid-phase Oligonucleotide Synthesis Forecasted Market Size by Region (2025-2030)

2.3 Solid-phase Oligonucleotide Synthesis Market Dynamics

2.3.1 Solid-phase Oligonucleotide Synthesis Industry Trends

2.3.2 Solid-phase Oligonucleotide Synthesis Market Drivers

2.3.3 Solid-phase Oligonucleotide Synthesis Market Challenges

2.3.4 Solid-phase Oligonucleotide Synthesis Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Solid-phase Oligonucleotide Synthesis Players by Revenue

3.1.1 Global Top Solid-phase Oligonucleotide Synthesis Players by Revenue (2019-2024)

3.1.2 Global Solid-phase Oligonucleotide Synthesis Revenue Market Share by Players (2019-2024)

3.2 Global Solid-phase Oligonucleotide Synthesis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Solid-phase Oligonucleotide Synthesis Revenue

3.4 Global Solid-phase Oligonucleotide Synthesis Market Concentration Ratio

3.4.1 Global Solid-phase Oligonucleotide Synthesis Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Solid-phase Oligonucleotide Synthesis Revenue in 2023

3.5 Solid-phase Oligonucleotide Synthesis Key Players Head office and Area Served

3.6 Key Players Solid-phase Oligonucleotide Synthesis Product Solution and Service

3.7 Date of Enter into Solid-phase Oligonucleotide Synthesis Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Solid-phase Oligonucleotide Synthesis Breakdown Data by Type

4.1 Global Solid-phase Oligonucleotide Synthesis Historic Market Size by Type (2019-2024)

4.2 Global Solid-phase Oligonucleotide Synthesis Forecasted Market Size by Type (2025-2030)

5 Solid-phase Oligonucleotide Synthesis Breakdown Data by Application

5.1 Global Solid-phase Oligonucleotide Synthesis Historic Market Size by Application (2019-2024)

5.2 Global Solid-phase Oligonucleotide Synthesis Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Solid-phase Oligonucleotide Synthesis Market Size (2019-2030)

6.2 North America Solid-phase Oligonucleotide Synthesis Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Solid-phase Oligonucleotide Synthesis Market Size by Country (2019-2024)

6.4 North America Solid-phase Oligonucleotide Synthesis Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Solid-phase Oligonucleotide Synthesis Market Size (2019-2030)

7.2 Europe Solid-phase Oligonucleotide Synthesis Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Solid-phase Oligonucleotide Synthesis Market Size by Country (2019-2024)

7.4 Europe Solid-phase Oligonucleotide Synthesis Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Solid-phase Oligonucleotide Synthesis Market Size (2019-2030)

8.2 Asia-Pacific Solid-phase Oligonucleotide Synthesis Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Solid-phase Oligonucleotide Synthesis Market Size by Region (2019-2024)

8.4 Asia-Pacific Solid-phase Oligonucleotide Synthesis Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Solid-phase Oligonucleotide Synthesis Market Size (2019-2030)

9.2 Latin America Solid-phase Oligonucleotide Synthesis Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Solid-phase Oligonucleotide Synthesis Market Size by Country (2019-2024)

9.4 Latin America Solid-phase Oligonucleotide Synthesis Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Size (2019-2030)

10.2 Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Size by Country (2019-2024)

10.4 Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Genescript

11.1.1 Genescript Company Detail

11.1.2 Genescript Business Overview

11.1.3 Genescript Solid-phase Oligonucleotide Synthesis Introduction

11.1.4 Genescript Revenue in Solid-phase Oligonucleotide Synthesis Business (2019-2024)

11.1.5 Genescript Recent Development

11.2 GeneArt (Thermofischer)

11.2.1 GeneArt (Thermofischer) Company Detail

11.2.2 GeneArt (Thermofischer) Business Overview

11.2.3 GeneArt (Thermofischer) Solid-phase Oligonucleotide Synthesis Introduction

11.2.4 GeneArt (Thermofischer) Revenue in Solid-phase Oligonucleotide Synthesis Business (2019-2024)

11.2.5 GeneArt (Thermofischer) Recent Development

11.3 Renesas Electronics Corporation

11.3.1 Renesas Electronics Corporation Company Detail

11.3.2 Renesas Electronics Corporation Business Overview

11.3.3 Renesas Electronics Corporation Solid-phase Oligonucleotide Synthesis Introduction

11.3.4 Renesas Electronics Corporation Revenue in Solid-phase Oligonucleotide Synthesis Business (2019-2024)

11.3.5 Renesas Electronics Corporation Recent Development

11.4 DNA 2.0 (ATUM)

11.4.1 DNA 2.0 (ATUM) Company Detail

11.4.2 DNA 2.0 (ATUM) Business Overview

11.4.3 DNA 2.0 (ATUM) Solid-phase Oligonucleotide Synthesis Introduction

11.4.4 DNA 2.0 (ATUM) Revenue in Solid-phase Oligonucleotide Synthesis Business (2019-2024)

11.4.5 DNA 2.0 (ATUM) Recent Development

11.5 OriGene

11.5.1 OriGene Company Detail

11.5.2 OriGene Business Overview

11.5.3 OriGene Solid-phase Oligonucleotide Synthesis Introduction

11.5.4 OriGene Revenue in Solid-phase Oligonucleotide Synthesis Business (2019-2024)

11.5.5 OriGene Recent Development

11.6 BBI

11.6.1 BBI Company Detail

11.6.2 BBI Business Overview

11.6.3 BBI Solid-phase Oligonucleotide Synthesis Introduction

11.6.4 BBI Revenue in Solid-phase Oligonucleotide Synthesis Business (2019-2024)

11.6.5 BBI Recent Development

11.7 Genewiz

11.7.1 Genewiz Company Detail

11.7.2 Genewiz Business Overview

11.7.3 Genewiz Solid-phase Oligonucleotide Synthesis Introduction

11.7.4 Genewiz Revenue in Solid-phase Oligonucleotide Synthesis Business (2019-2024)

11.7.5 Genewiz Recent Development

11.8 Eurofins Genomics

11.8.1 Eurofins Genomics Company Detail

11.8.2 Eurofins Genomics Business Overview

11.8.3 Eurofins Genomics Solid-phase Oligonucleotide Synthesis Introduction

11.8.4 Eurofins Genomics Revenue in Solid-phase Oligonucleotide Synthesis Business (2019-2024)

11.8.5 Eurofins Genomics Recent Development

11.9 Gene Oracle

11.9.1 Gene Oracle Company Detail

11.9.2 Gene Oracle Business Overview

11.9.3 Gene Oracle Solid-phase Oligonucleotide Synthesis Introduction

11.9.4 Gene Oracle Revenue in Solid-phase Oligonucleotide Synthesis Business (2019-2024)

11.9.5 Gene Oracle Recent Development

11.10 SBS Genetech

11.10.1 SBS Genetech Company Detail

11.10.2 SBS Genetech Business Overview

11.10.3 SBS Genetech Solid-phase Oligonucleotide Synthesis Introduction

11.10.4 SBS Genetech Revenue in Solid-phase Oligonucleotide Synthesis Business (2019-2024)

11.10.5 SBS Genetech Recent Development

11.11 Bio Basic

11.11.1 Bio Basic Company Detail

11.11.2 Bio Basic Business Overview

11.11.3 Bio Basic Solid-phase Oligonucleotide Synthesis Introduction

11.11.4 Bio Basic Revenue in Solid-phase Oligonucleotide Synthesis Business (2019-2024)

11.11.5 Bio Basic Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details
List of Tables
List of Tables

Table 1. Global Solid-phase Oligonucleotide Synthesis Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Primers

Table 3. Key Players of Probes

Table 4. Key Players of Intermediate-scale Synthesis Oligos

Table 5. Key Players of Large-scale Synthesis Oligos

Table 6. Key Players of Linkers and Adaptors

Table 7. Global Solid-phase Oligonucleotide Synthesis Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Solid-phase Oligonucleotide Synthesis Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global Solid-phase Oligonucleotide Synthesis Market Size by Region (2019-2024) & (US$ Million)

Table 10. Global Solid-phase Oligonucleotide Synthesis Market Share by Region (2019-2024)

Table 11. Global Solid-phase Oligonucleotide Synthesis Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 12. Global Solid-phase Oligonucleotide Synthesis Market Share by Region (2025-2030)

Table 13. Solid-phase Oligonucleotide Synthesis Market Trends

Table 14. Solid-phase Oligonucleotide Synthesis Market Drivers

Table 15. Solid-phase Oligonucleotide Synthesis Market Challenges

Table 16. Solid-phase Oligonucleotide Synthesis Market Restraints

Table 17. Global Solid-phase Oligonucleotide Synthesis Revenue by Players (2019-2024) & (US$ Million)

Table 18. Global Solid-phase Oligonucleotide Synthesis Market Share by Players (2019-2024)

Table 19. Global Top Solid-phase Oligonucleotide Synthesis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Solid-phase Oligonucleotide Synthesis as of 2023)

Table 20. Ranking of Global Top Solid-phase Oligonucleotide Synthesis Companies by Revenue (US$ Million) in 2023

Table 21. Global 5 Largest Players Market Share by Solid-phase Oligonucleotide Synthesis Revenue (CR5 and HHI) & (2019-2024)

Table 22. Key Players Headquarters and Area Served

Table 23. Key Players Solid-phase Oligonucleotide Synthesis Product Solution and Service

Table 24. Date of Enter into Solid-phase Oligonucleotide Synthesis Market

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Solid-phase Oligonucleotide Synthesis Market Size by Type (2019-2024) & (US$ Million)

Table 27. Global Solid-phase Oligonucleotide Synthesis Revenue Market Share by Type (2019-2024)

Table 28. Global Solid-phase Oligonucleotide Synthesis Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 29. Global Solid-phase Oligonucleotide Synthesis Revenue Market Share by Type (2025-2030)

Table 30. Global Solid-phase Oligonucleotide Synthesis Market Size by Application (2019-2024) & (US$ Million)

Table 31. Global Solid-phase Oligonucleotide Synthesis Revenue Market Share by Application (2019-2024)

Table 32. Global Solid-phase Oligonucleotide Synthesis Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 33. Global Solid-phase Oligonucleotide Synthesis Revenue Market Share by Application (2025-2030)

Table 34. North America Solid-phase Oligonucleotide Synthesis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. North America Solid-phase Oligonucleotide Synthesis Market Size by Country (2019-2024) & (US$ Million)

Table 36. North America Solid-phase Oligonucleotide Synthesis Market Size by Country (2025-2030) & (US$ Million)

Table 37. Europe Solid-phase Oligonucleotide Synthesis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. Europe Solid-phase Oligonucleotide Synthesis Market Size by Country (2019-2024) & (US$ Million)

Table 39. Europe Solid-phase Oligonucleotide Synthesis Market Size by Country (2025-2030) & (US$ Million)

Table 40. Asia-Pacific Solid-phase Oligonucleotide Synthesis Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 41. Asia-Pacific Solid-phase Oligonucleotide Synthesis Market Size by Region (2019-2024) & (US$ Million)

Table 42. Asia-Pacific Solid-phase Oligonucleotide Synthesis Market Size by Region (2025-2030) & (US$ Million)

Table 43. Latin America Solid-phase Oligonucleotide Synthesis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Latin America Solid-phase Oligonucleotide Synthesis Market Size by Country (2019-2024) & (US$ Million)

Table 45. Latin America Solid-phase Oligonucleotide Synthesis Market Size by Country (2025-2030) & (US$ Million)

Table 46. Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 47. Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Size by Country (2019-2024) & (US$ Million)

Table 48. Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Size by Country (2025-2030) & (US$ Million)

Table 49. Genescript Company Detail

Table 50. Genescript Business Overview

Table 51. Genescript Solid-phase Oligonucleotide Synthesis Product

Table 52. Genescript Revenue in Solid-phase Oligonucleotide Synthesis Business (2019-2024) & (US$ Million)

Table 53. Genescript Recent Development

Table 54. GeneArt (Thermofischer) Company Detail

Table 55. GeneArt (Thermofischer) Business Overview

Table 56. GeneArt (Thermofischer) Solid-phase Oligonucleotide Synthesis Product

Table 57. GeneArt (Thermofischer) Revenue in Solid-phase Oligonucleotide Synthesis Business (2019-2024) & (US$ Million)

Table 58. GeneArt (Thermofischer) Recent Development

Table 59. Renesas Electronics Corporation Company Detail

Table 60. Renesas Electronics Corporation Business Overview

Table 61. Renesas Electronics Corporation Solid-phase Oligonucleotide Synthesis Product

Table 62. Renesas Electronics Corporation Revenue in Solid-phase Oligonucleotide Synthesis Business (2019-2024) & (US$ Million)

Table 63. Renesas Electronics Corporation Recent Development

Table 64. DNA 2.0 (ATUM) Company Detail

Table 65. DNA 2.0 (ATUM) Business Overview

Table 66. DNA 2.0 (ATUM) Solid-phase Oligonucleotide Synthesis Product

Table 67. DNA 2.0 (ATUM) Revenue in Solid-phase Oligonucleotide Synthesis Business (2019-2024) & (US$ Million)

Table 68. DNA 2.0 (ATUM) Recent Development

Table 69. OriGene Company Detail

Table 70. OriGene Business Overview

Table 71. OriGene Solid-phase Oligonucleotide Synthesis Product

Table 72. OriGene Revenue in Solid-phase Oligonucleotide Synthesis Business (2019-2024) & (US$ Million)

Table 73. OriGene Recent Development

Table 74. BBI Company Detail

Table 75. BBI Business Overview

Table 76. BBI Solid-phase Oligonucleotide Synthesis Product

Table 77. BBI Revenue in Solid-phase Oligonucleotide Synthesis Business (2019-2024) & (US$ Million)

Table 78. BBI Recent Development

Table 79. Genewiz Company Detail

Table 80. Genewiz Business Overview

Table 81. Genewiz Solid-phase Oligonucleotide Synthesis Product

Table 82. Genewiz Revenue in Solid-phase Oligonucleotide Synthesis Business (2019-2024) & (US$ Million)

Table 83. Genewiz Recent Development

Table 84. Eurofins Genomics Company Detail

Table 85. Eurofins Genomics Business Overview

Table 86. Eurofins Genomics Solid-phase Oligonucleotide Synthesis Product

Table 87. Eurofins Genomics Revenue in Solid-phase Oligonucleotide Synthesis Business (2019-2024) & (US$ Million)

Table 88. Eurofins Genomics Recent Development

Table 89. Gene Oracle Company Detail

Table 90. Gene Oracle Business Overview

Table 91. Gene Oracle Solid-phase Oligonucleotide Synthesis Product

Table 92. Gene Oracle Revenue in Solid-phase Oligonucleotide Synthesis Business (2019-2024) & (US$ Million)

Table 93. Gene Oracle Recent Development

Table 94. SBS Genetech Company Detail

Table 95. SBS Genetech Business Overview

Table 96. SBS Genetech Solid-phase Oligonucleotide Synthesis Product

Table 97. SBS Genetech Revenue in Solid-phase Oligonucleotide Synthesis Business (2019-2024) & (US$ Million)

Table 98. SBS Genetech Recent Development

Table 99. Bio Basic Company Detail

Table 100. Bio Basic Business Overview

Table 101. Bio Basic Solid-phase Oligonucleotide Synthesis Product

Table 102. Bio Basic Revenue in Solid-phase Oligonucleotide Synthesis Business (2019-2024) & (US$ Million)

Table 103. Bio Basic Recent Development

Table 104. Research Programs/Design for This Report

Table 105. Key Data Information from Secondary Sources

Table 106. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Solid-phase Oligonucleotide Synthesis Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Solid-phase Oligonucleotide Synthesis Market Share by Type: 2023 VS 2030

Figure 3. Primers Features

Figure 4. Probes Features

Figure 5. Intermediate-scale Synthesis Oligos Features

Figure 6. Large-scale Synthesis Oligos Features

Figure 7. Linkers and Adaptors Features

Figure 8. Global Solid-phase Oligonucleotide Synthesis Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 9. Global Solid-phase Oligonucleotide Synthesis Market Share by Application: 2023 VS 2030

Figure 10. Commercial Case Studies

Figure 11. Academic Research Case Studies

Figure 12. Solid-phase Oligonucleotide Synthesis Report Years Considered

Figure 13. Global Solid-phase Oligonucleotide Synthesis Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Solid-phase Oligonucleotide Synthesis Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Solid-phase Oligonucleotide Synthesis Market Share by Region: 2023 VS 2030

Figure 16. Global Solid-phase Oligonucleotide Synthesis Market Share by Players in 2023

Figure 17. Global Top Solid-phase Oligonucleotide Synthesis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Solid-phase Oligonucleotide Synthesis as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Solid-phase Oligonucleotide Synthesis Revenue in 2023

Figure 19. North America Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Solid-phase Oligonucleotide Synthesis Market Share by Country (2019-2030)

Figure 21. United States Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Solid-phase Oligonucleotide Synthesis Market Share by Country (2019-2030)

Figure 25. Germany Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. France Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. U.K. Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Italy Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Russia Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Nordic Countries Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Solid-phase Oligonucleotide Synthesis Market Share by Region (2019-2030)

Figure 33. China Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Japan Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. South Korea Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Southeast Asia Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. India Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Australia Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Solid-phase Oligonucleotide Synthesis Market Share by Country (2019-2030)

Figure 41. Mexico Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Brazil Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Share by Country (2019-2030)

Figure 45. Turkey Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Saudi Arabia Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Genescript Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2019-2024)

Figure 48. GeneArt (Thermofischer) Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2019-2024)

Figure 49. Renesas Electronics Corporation Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2019-2024)

Figure 50. DNA 2.0 (ATUM) Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2019-2024)

Figure 51. OriGene Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2019-2024)

Figure 52. BBI Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2019-2024)

Figure 53. Genewiz Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2019-2024)

Figure 54. Eurofins Genomics Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2019-2024)

Figure 55. Gene Oracle Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2019-2024)

Figure 56. SBS Genetech Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2019-2024)

Figure 57. Bio Basic Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2019-2024)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’